# HALOPERIDOL
> **ANDA210356** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2019-07-01
## Drug
- **FDA Application Number:** ANDA210356
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HALOPERIDOL
- **Generic name:** HALOPERIDOL LACTATE
- **Active ingredients:** HALOPERIDOL LACTATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2019-07-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210356)
---
*AI Analytics · CC0 1.0*